Mahmoud Kassem

720 total citations
30 papers, 429 citations indexed

About

Mahmoud Kassem is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mahmoud Kassem has authored 30 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in Mahmoud Kassem's work include HER2/EGFR in Cancer Research (4 papers), BRCA gene mutations in cancer (2 papers) and Pharmacology and Obesity Treatment (2 papers). Mahmoud Kassem is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), BRCA gene mutations in cancer (2 papers) and Pharmacology and Obesity Treatment (2 papers). Mahmoud Kassem collaborates with scholars based in United States, Egypt and Vietnam. Mahmoud Kassem's co-authors include Mathew Cherian, Robert Wesolowski, Sagar Sardesai, Dionisia Quiroga, William E. Carson, Brooke Benner, Thomas E Schultz, Bhuvaneswari Ramaswamy, Maryam B. Lustberg and Daniel G. Stover and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Mahmoud Kassem

21 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahmoud Kassem United States 12 111 110 76 72 64 30 429
Roshan Karki United States 10 174 1.6× 84 0.8× 40 0.5× 50 0.7× 44 0.7× 23 505
Yongqiang Zheng China 17 156 1.4× 169 1.5× 78 1.0× 96 1.3× 27 0.4× 43 551
Denise Lowe United States 14 100 0.9× 134 1.2× 62 0.8× 36 0.5× 60 0.9× 26 485
Shiyama Mudali United States 7 89 0.8× 171 1.6× 66 0.9× 129 1.8× 50 0.8× 7 480
Antonia Sioga Greece 10 82 0.7× 52 0.5× 81 1.1× 31 0.4× 41 0.6× 54 383
Marı́a Cristina Morán-Moguel Mexico 14 216 1.9× 93 0.8× 47 0.6× 30 0.4× 104 1.6× 42 567
Guoqiang Bao China 12 147 1.3× 74 0.7× 37 0.5× 61 0.8× 44 0.7× 35 437
Maya Suzuki Japan 9 106 1.0× 149 1.4× 54 0.7× 34 0.5× 22 0.3× 35 359
Kouichi Murakami Japan 14 104 0.9× 56 0.5× 64 0.8× 35 0.5× 116 1.8× 26 598

Countries citing papers authored by Mahmoud Kassem

Since Specialization
Citations

This map shows the geographic impact of Mahmoud Kassem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud Kassem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud Kassem more than expected).

Fields of papers citing papers by Mahmoud Kassem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud Kassem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud Kassem. The network helps show where Mahmoud Kassem may publish in the future.

Co-authorship network of co-authors of Mahmoud Kassem

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud Kassem. A scholar is included among the top collaborators of Mahmoud Kassem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud Kassem. Mahmoud Kassem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kassem, Mahmoud, et al.. (2025). Effects of triptolide herb on the progression of Alzheimer’s disease preclinical models: a systematic review. Neurodegenerative Disease Management. 16(2). 239–251.
3.
Goldstein, Daniel A., Dionisia Quiroga, Mahmoud Kassem, et al.. (2023). The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and Therapy. 11(3). 361–374. 1 indexed citations
4.
Kassem, Mahmoud, et al.. (2023). Efficacy of the Radiofrequency Identification Technique in Breast Cancer Patients: A Single Institution Retrospective Study. SHILAP Revista de lepidopterología. 20(1). 52–56.
5.
Vuong, Lan N., Muhammed Elhadi, Sedighe Karimzadeh, et al.. (2022). Saphenous vein harvesting techniques for coronary artery bypass grafting: a systematic review and meta-analysis.. PubMed. 33(2). 128–136. 1 indexed citations
6.
Palettas, Marilly, Michael Grimm, Mahmoud Kassem, et al.. (2022). Abstract P4-09-08: Examining neurocognitive function in breast-cancer patients after chemotherapy. Cancer Research. 82(4_Supplement). P4–9.
7.
Tawfik, Gehad Mohamed, Omar Mohamed Makram, Sherief Ghozy, et al.. (2021). Voice Rehabilitation by Voice Prostheses After Total Laryngectomy: A Systematic Review and Network Meta-Analysis for 11,918 Patients. Journal of Speech Language and Hearing Research. 64(7). 2668–2681. 5 indexed citations
9.
Sukumar, Jasmine, Dionisia Quiroga, Mahmoud Kassem, et al.. (2021). Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer. Breast Cancer Research and Treatment. 190(2). 183–188. 14 indexed citations
10.
Williams, Nicole, Richard G. Paxman, Mahmoud Kassem, et al.. (2021). Real-world data on usage of scalp cooling for chemotherapy associated alopecia in the United States.. Journal of Clinical Oncology. 39(15_suppl). e18739–e18739. 1 indexed citations
11.
Benner, Brooke, et al.. (2020). Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development. SHILAP Revista de lepidopterología. 4 indexed citations
12.
Benner, Brooke, Dionisia Quiroga, Thomas E Schultz, et al.. (2020). <p>Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development</p>. Drug Design Development and Therapy. Volume 14. 1693–1704. 121 indexed citations
13.
Sardesai, Sagar, Mohamed Badawi, Ewa Mrózek, et al.. (2020). A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Investigational New Drugs. 38(5). 1400–1410. 24 indexed citations
14.
Kassem, Mahmoud, Gary Tozbikian, Julia White, et al.. (2020). TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature. Frontiers in Endocrinology. 11. 228–228. 12 indexed citations
15.
Sardesai, Sagar, Jasmine Sukumar, Mahmoud Kassem, et al.. (2020). Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer. Cardio-Oncology. 6(1). 26–26. 22 indexed citations
16.
Tam, Dao Ngoc Hien, et al.. (2019). Efficacy of chalcone and xanthine derivatives on lipase inhibition: A systematic review. Chemical Biology & Drug Design. 95(2). 205–214. 7 indexed citations
17.
Kassem, Mahmoud, et al.. (2019). Low Pressure versus Standard Pressure Pneumoperitoneum in Laparoscopic Cholecystectomy. The Egyptian Journal of Hospital Medicine. 75(3). 2499–2504. 1 indexed citations
18.
Elshafay, Abdelrahman, Truong Hong Hieu, Mohamed Fahmy Doheim, et al.. (2019). Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis. CNS Drugs. 33(3). 239–250. 15 indexed citations
19.
Kassem, Mahmoud, et al.. (2017). The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events. Frontiers in Endocrinology. 8. 37–37. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026